CRDO
Credo Technology Group Holding Ltd
$171.51
-0.75% 2026-10-20
Technology
CRDOSPY
1W
-13.5%
1M
-2.5%
3M
-23.4%
6M
-6.4%
YTD
+19.2%
1Y
+13.1%
Live chart
Loading live chart…
Grades vs sector
MomentumNot enough data yet–
Momentum
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
GrowthNot enough data yet–
Growth
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ValueNot enough data yet–
Value
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
ProfitabilityNot enough data yet–
Profitability
Not enough data yet
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
Revisions
Not enough data yet
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
Momentum Top 15
not ranked (outside this model's universe or screens)
Quality Growthnot ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
New Highs Growthnot ranked (outside this model's universe or screens)
Conviction 20not in the current book
News
More newsOne Stock That Could Become Much More Important to AI
24/7 Wall St. · Oct 16
CRDO vs. COHR: Which AI Connectivity Stock Is the Better Buy?
Zacks · Oct 15
Key stats
Market cap$32.2B
P/E (trailing)60.8
P/E (forward)17.7
52-week range86.48 – 308.67
Revenue growth (YoY, latest qtr)+114.7%
Dividend yield0.00%
Analyst consensusStrong Buy (20)
Mean price target$279.09 (+63%)
Valuation and fundamentals
Valuation & fundamentals
Bottom line
Leans undervalued
Model read-out from the numbers below, not advice. Score +2 (DCF counts double).
•DCF (base case)below the price by 7%
▲Piotroski F-score7/9
▲Altman Z69.9 (safe)
▲Net debt / EBITDA-1.4x
▲Analyst target+63% (20 analysts)
Discounted cash flow
Bear
$72
-58%
growth 18% · disc. 10.2% · term. 2.0%
Base
$160
-7%
growth 30% · disc. 9.2% · term. 2.5%
Bull
$301
+76%
growth 38% · disc. 8.2% · term. 3.0%
A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Today's price assumes free cash flow grows about 23% a year for 10 years.
Implied
+23%/yr
FCF, last 3 yrs
n/a
FCF, last 5 yrs
n/a
Revenue, last 3 yrs
+94%/yr
Revenue, last 5 yrs
+87%/yr
Same inputs as the DCF above: trailing free cash flow 0.4B, 9.2% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2026; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-08-01). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 3.25 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs sector
Forward EPS $9.69 vs trailing $2.82 (+244% expected growth). Forward P/E uses analysts' next-12-month estimate.
Quality & financial health
Gross margin
67.1%
Operating margin
31.7%
FCF margin
27.6%
Net margin
33.8%
Return on equity
19.7%
Return on invested capital
25.6%
Net debt / EBITDA
-1.4×
Current ratio
7.4×
Interest cover
–
Cash conversion (OCF/NI)
0.9×
Piotroski F-score 7/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✗ Cash flow above net income✓ Long-term debt / assets fell✓ Current ratio improved✗ No share dilution✓ Gross margin improved✓ Asset turnover improved
Altman Z-score 69.9 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Mean target
$279
+63%
Analysts
20
Strong Buy
Range
$185–$315
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2026 | $1.3B | $472.3M | $407.0M |
| 2025 | $436.8M | $52.2M | $29.0M |
| 2024 | $193.0M | $-28.4M | $17.1M |
| 2023 | $184.2M | $-16.5M | $-46.3M |
| 2022 | $106.5M | $-22.2M | $-48.4M |
| 2021 | $58.7M | $-27.5M | $-48.4M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +93.5%.
Earnings
Next report: 2026-11-30 · during market · EPS est 1.28
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-09-01 | 1.17 | 1.20 | +2.7% |
| 2026-06-01 | 1.03 | 1.16 | +12.2% |
| 2026-03-02 | 0.94 | 1.07 | +13.7% |
| 2025-12-01 | 0.50 | 0.67 | +35.3% |
| 2025-09-03 | 0.36 | 0.52 | +44.2% |
| 2025-06-02 | 0.27 | 0.35 | +27.9% |
| 2025-03-04 | 0.18 | 0.25 | +36.5% |
| 2024-12-02 | 0.05 | 0.07 | +34.6% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-07-31 | $479.0M | +114.7% |
| 2026-04-30 | $437.0M | – |
| 2026-01-31 | $407.0M | – |
| 2025-10-31 | $268.0M | – |
| 2025-07-31 | $223.1M | – |
Analyst actions
Rosenblatt
PT $235
2026-10-15 · main
Neutral → NeutralPT $235
Stifel
PT $310
2026-10-05 · main
Buy → BuyPT $310
Mizuho
PT $245
2026-09-21 · main
Outperform → OutperformPT $245
JP Morgan
PT $310
2026-09-02 · main
Overweight → OverweightPT $310
Evercore ISI Group
PT $292
2026-09-02 · main
Outperform → OutperformPT $292
Rosenblatt
PT $235
2026-09-02 · main
Neutral → NeutralPT $235
Insider trades
Cheng Chi Fung
$271.0K
Director, Chief Technology Officer · 2026-10-13
SELL$271.0K
Cheng Chi Fung
$270.5K
Director, Chief Technology Officer · 2026-10-13
SELL$270.5K
Cheng Chi Fung
$564.5K
Director, Chief Technology Officer · 2026-10-13
SELL$564.5K
Cheng Chi Fung
$596.4K
Director, Chief Technology Officer · 2026-10-13
SELL$596.4K
Cheng Chi Fung
$295.0K
Director, Chief Technology Officer · 2026-10-13
SELL$295.0K
Cheng Chi Fung
$249.0K
Director, Chief Technology Officer · 2026-10-13
SELL$249.0K
Cheng Chi Fung
$192.3K
Director, Chief Technology Officer · 2026-10-13
SELL$192.3K
Cheng Chi Fung
$523.0K
Director, Chief Technology Officer · 2026-10-13
SELL$523.0K
Cheng Chi Fung
$233.4K
Director, Chief Technology Officer · 2026-10-13
SELL$233.4K
Cheng Chi Fung
$488.9K
Director, Chief Technology Officer · 2026-10-13
SELL$488.9K
Cheng Chi Fung
$275.3K
Director, Chief Technology Officer · 2026-10-13
SELL$275.3K
Cheng Chi Fung
$664.8K
Director, Chief Technology Officer · 2026-10-13
SELL$664.8K
Stats refreshed 2026-10-20 17:52:28 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteauCoteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.